Els Van Nieuwenhuysen (E Van Nieuwenhuysen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Positive Breast Cancer

Estrogen Receptor

Diffusion Weighted

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Annals of medicine and surgery (2012)

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tine Ottenbourgs, Toon Van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Tine Ottenbourgs, Toon Van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Tine Ottenbourgs, Els Van Nieuwenhuysen
Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer? Cancers 16 (10) (2024)
Tine Ottenbourgs, Toon Van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Tine Ottenbourgs, Toon Van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Tine Ottenbourgs, Els Van Nieuwenhuysen
Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer? Cancers 16 (10) (2024)
Charles N Landen, Luciana L Molinero, Habib Hamidi, Jalid Sehouli, Austin Miller, Kathleen M Moore, Cagatay Taskıran, Michael A Bookman, Kristina Lindemann, Charles Anderson, Regina Berger, Tashanna Myers, Mario Beiner, Thomas Reid, Els Van Nieuwenhuysen, Andrew Green, Aikou Okamoto, Carol Aghajanian, Premal H Thaker, Stephanie V Blank, Victor K Khor, Ching-Wei Chang, Yvonne G Lin, Sandro Pignata
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sander Dumont, Vincent Vandecaveye, Raphaëla Carmen Dresen, Els Van Nieuwenhuysen, Thaïs Baert, Frédéric Amant, Valérie Broeckhoven, Toon Van Gorp
Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Jolien Jansen, Eva Oldenburger, Jente Jansen, Albert Wolthuis, Els Van Nieuwenhuysen, Patrick Neven, Ignace Vergote, Sileny N Han
Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study. Annals of medicine and surgery (2012) 85 (5) (2023)
S Thijssen, Hans P M W Wildiers, Kevin Punie, Benoit Beuselinck, P Clement, C Remmerie, P Berteloot, Sileny N Han, Els Van Nieuwenhuysen, Toon Van Gorp, Ignace Vergote, Ann Smeets, Ines Nevelsteen, Giuseppe Floris, Caroline Weltens, Johan Menten, H Janssen, A Laenen, Patrick Neven
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort. Journal of cancer research and clinical oncology 147 (4) (2021)